BioMarin Pharmaceutical (BMRN) Market Cap 1999–2026

As of November 13, 2026, BioMarin Pharmaceutical had a market cap of $11.08 billion, which increased by 0.91% compared to the previous trading day. Market capitalization, often referred to as market cap, represents the total value of a company's outstanding shares on the stock market and is a common measure of its overall size and valuation.

Data updated: Nov 13, 2026, 4:00 PM ET
BioMarin Pharmaceutical logo

BioMarin Pharmaceutical Inc. (BMRN)

🌍 United States 📈 NASDAQ 🏭 Health Care 🏢 Biotechnology
Latest Market Cap
$11.08B ▲ 0.91%
Start of 2026
$11.42B ▼ 2.98%
1 Year Ago
$10.42B ▲ 6.33%
All-Time High
$24.011B ▼ 53.86%


Loading data...

Note: Each point on the chart represents the market capitalization at the end of the trading day.
Source: Data compiled from EDGAR filings, Bloomberg and Yahoo Finance.

📈 BioMarin Pharmaceutical Market Cap History by Year and Month

BioMarin Pharmaceutical Market Cap History by Year and Month
Year / MonthMarket Cap% Change
2026$11.08B▼ 2.98%
$11.08B▼ 2.12%
$11.32B▼ 2.50%
$11.61B▼ 8.00%
$12.62B▲ 8.79%
$11.6B▲ 4.88%
$11.06B▼ 0.09%
$11.07B▲ 6.75%
$10.37B▼ 4.51%
$10.86B▼ 8.43%
$11.86B▲ 9.21%
$10.86B▼ 4.90%
2025$11.42B▼ 8.92%
2024$12.539B▼ 30.96%
2023$18.163B▼ 5.57%
2022$19.234B▲ 18.37%
All market cap values reflect closing prices for the period shown.

📊 BioMarin Pharmaceutical Market Cap and Other Industry Peers

Below are selected companies for comparison based on industry, sub-industry, and sector:

  1. $16.96B
  2. $16.88B
  3. $15.35B
  4. $11.42B
  5. $11.32B
  6. $11.08B
  7. $10.88B
  8. $9.93B
  9. $9.46B
  10. $9.17B
  11. $9.04B
  12. $8.54B
  13. $7.97B
  14. $7.81B
  15. $6.74B
  16. $6.61B
  17. $5.3B
  18. $5.19B
  19. $4.97B
  20. $4.84B

Data reflect the most recent market capitalization values available.

Note: Market capitalization figures are based on available sources and may differ slightly from actual values, particularly for historical data.